Shares of Exponent, Inc. (NASDAQ:EXPO) have earned an average broker rating score of 1.67 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company. Exponent’s rating score has improved by 28.3% from 90 days ago as a result of a number of analysts’ ratings changes.
Analysts have set a one year consensus price objective of $84.00 for the company and are expecting that the company will post $0.62 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Exponent an industry rank of 78 out of 265 based on the ratings given to related companies.
Several analysts have commented on the stock. BidaskClub raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, February 5th. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “buy” rating and set a $88.00 target price for the company in a research report on Tuesday, February 27th. Finally, SunTrust Banks raised shares of Exponent from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research report on Friday, January 26th.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.47 EPS for the quarter, beating the Zacks’ consensus estimate of $0.42 by $0.05. The firm had revenue of $82.72 million for the quarter, compared to the consensus estimate of $80.27 million. Exponent had a net margin of 11.88% and a return on equity of 17.81%. The firm’s revenue was up 13.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.39 earnings per share. sell-side analysts predict that Exponent will post 2.41 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 23rd. Shareholders of record on Friday, March 2nd will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 1.31%. This is an increase from Exponent’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Thursday, March 1st. Exponent’s payout ratio is currently 68.42%.
A number of hedge funds have recently bought and sold shares of the business. Envestnet Asset Management Inc. grew its position in Exponent by 5.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 32,775 shares of the business services provider’s stock worth $2,330,000 after acquiring an additional 1,836 shares in the last quarter. MetLife Investment Advisors LLC bought a new stake in Exponent in the fourth quarter worth approximately $881,000. Jane Street Group LLC bought a new stake in Exponent in the fourth quarter worth approximately $453,000. Crestline Management LP bought a new stake in Exponent in the fourth quarter worth approximately $1,979,000. Finally, Millennium Management LLC grew its position in Exponent by 557.1% in the fourth quarter. Millennium Management LLC now owns 113,998 shares of the business services provider’s stock worth $8,105,000 after acquiring an additional 96,650 shares in the last quarter. 88.91% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Exponent, Inc. (EXPO) Given Average Rating of “Buy” by Analysts” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://stocknewstimes.com/2018/03/22/exponent-inc-expo-given-average-rating-of-buy-by-analysts.html.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.